NCT00000210
Completed
Phase 2
Treatment Efficacy for Drug Abuse and AIDS Prevention
DrugsBuprenorphine
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Cocaine-Related Disorders
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Locations
- 1
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to assess the safety and effectiveness of buprenorphine for treatment of concurrent intravenous heroin and cocaine dependence.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Treatment Efficacy for Drug Abuse and AIDS Prevention - 2Cocaine-Related DisordersHeroin DependenceNCT00000211National Institute on Drug Abuse (NIDA)
Completed
Phase 2
Cocaine Use Reduction With BuprenorphineCocaine DependenceNCT01402492University of California, Los Angeles302
Completed
Not Applicable
Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary CareHeroin DependenceOpioid-Related DisordersSubstance Abuse, IntravenousNCT00471042New York State Psychiatric Institute30
Completed
Phase 2
Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent ParticipantsOpiate DependenceHIV SeropositivityHIV InfectionsNCT00130819Johns Hopkins University120
Completed
Phase 2
Buprenorphine Maintenance for Opioid Addicts - 1Opioid-Related DisordersNCT00000202Yale University